| Date Filed | Type | Description |
| 12/05/2017 |
8-K
| Filed for Chapter 11 |
| 12/01/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/14/2017 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 11/13/2017 |
8-K
| Termination of a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation o... |
| 10/26/2017 |
8-K
| Quarterly results |
| 10/16/2017 |
8-K
| Quarterly results |
| 10/04/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/29/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 09/11/2017 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 08/29/2017 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 08/25/2017 |
8-K
| Quarterly results |
| 08/18/2017 |
10-Q
| Quarterly Report for the period ended June 30, 2017 |
| 08/14/2017 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 06/28/2017 |
8-K
| Form 8-K - Current report |
| 05/19/2017 |
10-Q
| Quarterly Report for the period ended March 31, 2017 |
| 05/15/2017 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 04/24/2017 |
8-K
| Form 8-K - Current report |
| 04/14/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 04/05/2017 |
8-K
| Form 8-K - Current report |
| 04/04/2017 |
8-K
| Form 8-K - Current report |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2017 |
4
| ANTOLINE STEVE (10% Owner) has filed a Form 4 on Protea Biosciences Group, Inc.|
Txns:
| Acquired 16,564,248 shares
@ $0
Acquired 16,564,248 options to buy
@ $0 |
|
| 04/04/2017 |
4
| HOSTLER STANLEY (Secretary) has filed a Form 4 on Protea Biosciences Group, Inc.|
Txns:
| Acquired 6,000,000 shares
@ $0
Acquired 3,333,333 shares
@ $0
Acquired 6,000,000 options to buy
@ $0
Acquired 3,333,333 options to buy
@ $0 |
|
| 04/04/2017 |
4
| SEGAL SCOTT (Director) has filed a Form 4 on Protea Biosciences Group, Inc.|
Txns:
| Acquired 1,000,000 shares
@ $0
Acquired 1,000,000 options to buy
@ $0 |
|
| 04/04/2017 |
4
| HARRIS LEONARD P (Director) has filed a Form 4 on Protea Biosciences Group, Inc. |
| 03/31/2017 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| 03/28/2017 |
8-K
| Form 8-K - Current report |
| 03/02/2017 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/23/2017 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials |
| 02/21/2017 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials |
| 02/09/2017 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements |
| 12/16/2016 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/21/2016 |
10-Q
| Quarterly Report for the period ended September 30, 2016 |
| 11/17/2016 |
D
| Form D - Notice of Exempt Offering of Securities |
|